text:
Castle Biosciences Announces First Quarter 2021 Results
Q1 2021 revenues of $22.8 million, compared to $17.4 million in Q1 2020
Q1 2021 total dermatology test report volume of 4,805
Initiates 2021 Revenue Guidance of $80-83 million
Q1 2021 gross margin of 87%
Conference call and webcast today at 4:30 p.m. ET
FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #castlebiosciences–Castle Biosciences, Inc. (Nasdaq: CSTL), a dermatologic diagnostics company providing personalized genomic information to improve treatment decisions, today announced its financial results for the first quarter ended March 31, 2021.
"We are pleased with our strong execution in the first quarter, with revenue increasing by 31% over the first quarter of 2020," said Derek Maetzold, president and chief executive officer of Castle Biosciences. "In-line with our expectations, January and February were impacted, we believe, by COVID-19 and weather interruptions. However, we are encouraged by the positive trends that we are seeing. Specifically, we saw order volume for our DecisionDx®-Melanoma test increase by approximately 30% in March 2021, compared to January 2021, with March orders being the highest March since DecisionDx-Melanoma became commercially available. This positive trend continued in April, with April orders exceeding those of March. Additionally, we saw continued positive trends for our recently launched DecisionDx®-SCC and DecisionDx® DiffDx™-Melanoma tests. While there is continued uncertainty related to the impact of COVID-19 with regard to the timing of the return to historical levels of skin cancer diagnoses, we feel confident in providing 2021 revenue guidance of $80-83 million.
"We continue to make progress on our growth initiatives and remain focused on helping physicians answer clinical questions with high unmet need with the personalized, precise results our genomic tests are designed to provide. We believe our recent announcement of signing a definitive agreement to acquire Myriad's myPath Melanoma laboratory, and the resulting addition of myPath® Melanoma test to our skin cancer test services, furthers our position as the leader in dermatologic diagnostics. And we believe this enables us to provide the most comprehensive offerings for patients with skin cancer and difficult-to-diagnose melanocytic lesions. Additionally, our pipeline initiative to develop an innovative test that can predict therapy response and guide treatment selection of systemic therapies in patients diagnosed with moderate to severe psoriasis, atopic dermatitis and related conditions has the potential to expand our reach into non-skin cancer, medical dermatology diseases and is expected to provide enhanced value to our clinical customers and their patients. These tests, along with our other pipeline products, have the potential to increase our estimated U.S. total addressable market to slightly more than $5.5 billion.
"Finally, I am pleased to announce that we completed our commercial team expansion ahead of schedule, with all new outside territories filled, doubling our total dermatology customer facing positions to approximately 60-65. Training is ongoing, and by July 1, we expect our expanded commercial team will be able to utilize our existing, dermatologic sales channels to offer clinicians and their patients four innovative, actionable gene expression profile tests designed to improve patient care."
First Quarter Ended March 31, 2021, Selected Results
Revenues were $22.8 million, a 31% increase compared to $17.4 million during the same period in 2020. Included in revenue for the period were positive revenue adjustments related to tests delivered in prior periods. These positive prior period revenue adjustments for the three months ended March 31, 2021, were $5.3 million, compared to $3.2 million for the same period in 2020. Prior period revenues for the first quarter of 2021 includes favorable adjustments related to settlement of certain groups of receivables from prior years, in addition to other positive prior period revenue adjustments.
Adjusted revenues were $17.5 million, a 22% increase, excluding the effects of revenue adjustments related to tests delivered in prior periods, compared to $14.3 million for the same period in 2020.
Total gene expression profile test reports delivered in the first quarter of 2021 were 5,142, compared to 4,935 in the same period of 2020:
DecisionDx-Melanoma test reports delivered in the first quarter of 2021 were 4,060, compared to 4,574, in the first quarter of 2020.
DecisionDx-SCC test reports delivered in the first quarter of 2021 were 527.
DecisionDx DiffDx-Melanoma test reports delivered in the first quarter of 2021 were 218.
DecisionDx-UM test reports delivered in the first quarter of 2021 were 337, compared to 361 in the first quarter of 2020. Order volume for DecisionDx-UM increased by approximately 58% in March 2021, compared to January 2021.
Gross margin for the three months ended March 31, 2021, was 87%.
Adjusted gross margin for the three months ended March 31, 2021, was 83%.
Operating cash flow was $(3.6) million, compared to $(0.3) million for the same period in 2020.
Adjusted operating cash flow was $(5.5) million, compared to $(0.3) million for the same period in 2020.
As of March 31, 2021, the Company's cash and cash equivalents totaled $407 million.
2020 Revenue Guidance
Castle Biosciences anticipates generating $80-83 million in total revenue in 2021.
First Quarter and Recent Business and Clinical Evidence Highlights
On April 27, the Company announced it signed a definitive agreement to acquire all of the equity of Myriad myPath, LLC (Myriad myPath Laboratory), from Myriad Genetics. Myriad myPath Laboratory is a CLIA-certified laboratory in Salt Lake City, where the myPath Melanoma 23-gene expression profile (GEP) test is currently offered. With the acquisition, which is subject to customary closing conditions and is expected to close in late May 2021, Castle expects to make available the most comprehensive molecular testing offering for difficult-to-diagnose melanocytic lesions. See the Company's news release from April 27, 2021, for more information.
On May 10, the Company announced the launch of its innovative pipeline initiative to develop a genomic test aimed at predicting systemic therapy response in patients with moderate to severe psoriasis, atopic dermatitis and related conditions. See the Company's news release from earlier today for more information.
In April, at the 10th World Congress of Melanoma, the Company presented data on three of its skin cancer tests, including from an independent validation study demonstrating the i31-GEP artificial intelligence algorithm improves precision of sentinel lymph node positivity prediction in cutaneous melanoma. The poster, titled "Integration of the 31-gene expression profile test with clinicopathologic features (i31-GEP) to assess sentinel lymph node positivity risk in patients with cutaneous melanoma," highlights the i31-GEP validation study data and demonstrates that the algorithm provides a more precise, personalized likelihood of sentinel lymph node positivity. The poster can be accessed here.
Study methods and findings:
The study reviewed the development and validation of the i31-GEP, which deploys a neural network algorithm to integrate the continuous DecisionDx-Melanoma score as well as other histologic and clinical features on a development cohort of 1,398 patients. The i31-GEP algorithm was locked using these 1,398 patients and was then independently validated on an independent, U.S. based cohort of 1,674 patients.
The development phase identified that the DecisionDx-Melanoma score was the most important variable in predicting SLN positivity under both the variable importance assessment function (DecisionDx-Melanoma score = 100, Breslow thickness = 56, Mitotic rate = 25, ulceration = 83 and Age = 0; with 100 being the highest possible value) and log-likelihood value (DecisionDx-Melanoma score = 91.3, Breslow thickness = 53.5, Mitotic rate = 20.7, ulceration = 19.1 and Age = 10.5; with 100 being the highest possible value).
The independent validation phase showed that the i31-GEP provides a highly concordant prediction of SLN positivity rate compared to observed rates (linear regression slope of 0.999, with 1.0 representing complete concordance).
Of patients originally classified with 5-10% SLN positivity risk, i31-GEP reclassified 63% of those patients, whose actual risk of SLN positivity was outside that range in either direction (less than 5% or greater than 10%).
i31-GEP had a high negative predictive value of 98% in patients with T1-T4 tumors.
Information about the additional data presentations can be found here on the Company's news release from April 16, 2021.
Data from an independent, prospective study was published in the American Journal of Surgery, demonstrating DecisionDx-Melanoma's utility for prediction of outcomes in patients with cutaneous melanoma. The publication, titled "Utility of a 31-gene expression profile for predicting outcomes in patients with primary cutaneous melanoma referred for sentinel node biopsy," describes a study comparing tumor features, sentinel node biopsy (SLNB) results, and patient outcomes from a prospective database of 383 patients with cutaneous melanoma who both underwent SLNB and had their primary tumor assayed with DecisionDx-Melanoma. The study's results demonstrated that a Class 2 (high-risk) DecisionDx-Melanoma result was significantly associated with higher rates of SLNB positivity compared to Class 1 (low risk). With respect to risk prognoses, patients who received a Class 2B DecisionDx-Melanoma result and were SLNB-positive experienced the highest recurrence rates (38%), compared to only a 2% recurrence rate for patients who were Class 1A and SLNB-negative. DecisionDx-Melanoma Class 2 results were significantly associated with poorer RFS and DMFS rates compared to Class 1 results, both in the entire cohort of 383 cases and in patients staged as "low risk" (IA-IIA) according to American Joint Committee on Cancer (AJCC) staging criteria. See the Company's news release from April 14, 2021, for more information.
Publication of prospective, multi-center long-term outcomes data in cutaneous melanoma appeared in the peer-reviewed journal, JCO® Precision Oncology, and was titled "Long-term outcomes in a multicenter, prospective cohort evaluating the prognostic 31-gene expression profile for cutaneous melanoma." The study's key objective was to demonstrate the prognostic value of DecisionDx-Melanoma with long-term follow-up that extends the assessment time period for a previously studied cohort. The study achieved its primary objective and expanded upon prior results to show the ability of the test to accurately identifying recurrence risk of patients with American Joint Committee on Cancer (AJCC) 8th Edition staging system early stage I-IIA disease. See the Company's news release from April 13, 2021, for more information.
Publication of a cross-sectional study of dermatologists that found its respondents are increasingly incorporating DecisionDx®-Melanoma into the management of their patients with melanoma was published in SKIN: The Journal of Cutaneous Medicine and was titled, "Assessment of the 31-Gene Expression Profile Test by Dermatologists: A Cross-Sectional Survey from National Dermatology Conferences." The cross-sectional study was offered to attendees of two national, virtual dermatology conferences during the end of 2020 and beginning of 2021 to assess the professional understanding, opinions and clinical usage of DecisionDx-Melanoma by dermatologists. Participants were asked questions regarding practice demographics, factors considered prior to ordering DecisionDx-Melanoma, their integration of the test's results into clinical management and their opinions on the usefulness of the test. Participants who use DecisionDx-Melanoma indicated that they use the results to impact follow-up schedules, referrals, surveillance imaging, sentinel lymph node biopsy procedure recommendations and other treatment decisions. These uses largely follow published appropriate-use criteria for the test. Participants responded that patients gain various benefits from DecisionDx-Melanoma test results, including increased knowledge and understanding (70%), personalized treatment options (58%) and eased uncertainty about the future (59%). Even regarding test results indicating the lowest risk of recurrence (i.e., Class 1A), 66% of participants reported potential benefits for ameliorating patients' anxiety and 46% reported increasing confidence in their management. See the Company's news release from March 25, 2021, for more information.
In March 2021, the Company announced clinical availability of an artificial intelligence-based integrated DecisionDx-Melanoma test result. The Company validated the integration of clinicopathologic features with the tumor biology insights provided by the DecisionDx-Melanoma test. The integrated test result (ITR) is designed to provide a more precise risk prediction to further improve the clinical actionability by clinicians and their patients in helping to guide cancer management decisions. For more information, see the Company's news release from March 8, 2021.
In February 2021, the Company presented data on DecisionDx-Melanoma at the 19th Annual South Beach Symposium:
The first poster was entitled, "31-Gene expression profiling improves risk stratification in patients with T1 cutaneous melanoma." Univariate analysis of the study data showed DecisionDx-Melanoma to be a stronger predictor of recurrence-free survival (RFS) than SLN status. Additionally, multivariable analysis showed DecisionDx-Melanoma to be a strong, independent predictor of RFS. With Class 2B RFS status similar to SLN positive status, Class 2B patients warrant follow-up strategies similar to SLN positive patients.
The second DecisionDx-Melanoma poster was entitled, "The clinical and financial impact of the 31-gene expression profile testing on sentinel lymph node biopsy patients selection in patients with T1b cutaneous melanoma." The authors analyzed all clinical DecisionDx-Melanoma tests that were reported from Jan. 3, 2019 through Sept. 4, 2020. The data showed that 75% of eligible patients with T1b tumors had a Class 1A result and could potentially forego sentinel lymph node biopsy (SLNB). The authors estimate that foregoing SLNB in these patients could reduce healthcare expenditures by up to $120 million in SLNB-related costs. For more information, see the Company's news release from Feb. 4, 2021.
In January 2021, the Company presented data on DecisionDx-Melanoma and DecisionDx DiffDx-Melanoma at the 18th Annual Winter Clinical Dermatology Conference:
The virtual poster for DecisionDx-Melanoma was entitled, "Identifying predictors of sentinel lymph node metastasis in cutaneous melanoma patients using molecular and clinicopathologic high-risk features." For 3,093 patients with T1-T4 cutaneous melanoma, authors used decision tree analysis to determine which molecular and clinicopathologic features best stratify sentinel lymph node (SLN) positivity risk and demonstrated that DecisionDx-Melanoma was the most important feature in distinguishing between high and low SLN-positivity rates (p<0.001).
The virtual poster for DecisionDx DiffDx-Melanoma was entitled, "Performance of a 35-gene expression profile test in suspicious pigmented lesions of the head and neck." The study evaluated DecisionDx DiffDx-Melanoma's accuracy in classifying pigmented lesions on the head and neck. The data demonstrated that DecisionDx DiffDx-Melanoma has the ability to be an effective tool for refining melanoma diagnoses on the head and neck and therefore improving downstream management decisions, as indicated by its high sensitivity and specificity in the study. For more information, see the Company's news release from Jan. 20, 2021.
Also in January 2021, the Company presented data at the Maui Derm for Dermatologists 2021 conference:
The virtual poster for DecisionDx-SCC was entitled, "Clinical utility of the 40-gene expression profile (40-GEP) for improved patient management decisions and disease related outcomes when combined with current clinicopathological risk factors for cutaneous squamous cell carcinoma (cSCC): Case Series." Two SCC cases were presented that highlight DecisionDx-SCC's utility in stratifying risk in SCC. The cases had very similar risk of metastasis at diagnosis as both presented with a history of immunosuppression and had identical staging (T2a per Brigham and Women's Hospital staging; T1 per American Joint Committee on Cancer staging), but had divergent outcomes:
Case 1 did not recur, despite incomplete resection. This case had a low-risk (Class 1) DecisionDx-SCC result, consistent with the clinical outcome of no clinical progression.
Case 2 developed local recurrence and regional metastasis, and eventually died from SCC, despite clear surgical margins. This case had a highest-risk (Class 2B) DecisionDx-SCC result, consistent with clinical progression. The study authors concluded that incorporating DecisionDx-SCC as a prognostic factor with traditional clinicopathologic risk factors can improve stratification of high-risk SCC patients with at least one risk factor, thereby informing risk-appropriate management strategies.
Conference Call and Webcast Details
Castle Biosciences will hold a conference call on Monday, May 10, 2021, at 4:30 p.m. Eastern time to discuss its first quarter 2021 results and provide a corporate update.
A live webcast of the conference call can be accessed here: https://edge.media-server.com/mmc/p/p5gxkbjh or via the webcast link on the Investor Relations page of the Company's website (www.castlebiosciences.com). Please access the webcast at least 10 minutes before the conference call start time. An archive of the webcast will be available on the Company's website until June 1, 2021.
To access the live conference call via phone, please dial 877-282-2581 from the United States and Canada, or +1 470-495-9479 internationally, at least 10 minutes prior to the start of the call, using the conference ID 6526639.
There will be a brief Question & Answer session following management commentary.
Use of Non-GAAP Financial Measures (UNAUDITED)
In this release, we use the metrics of Adjusted Revenue, Adjusted Gross Margin and Adjusted Operating Cash Flow, which are non-GAAP financial measures and are not calculated in accordance with generally accepted accounting principles in the United States (GAAP). Adjusted Revenue and Adjusted Gross Margin reflect adjustments to net revenues to exclude changes in variable consideration related to test reports delivered in previous periods. Adjusted Operating Cash Flow excludes the effects of cash activity associated with COVID-19 government relief payments to healthcare providers.
We use Adjusted Revenue, Adjusted Gross Margin and Adjusted Operating Cash Flow internally because we believe these metrics provide useful supplemental information in assessing our revenue and cash flow performance, respectively. We believe Adjusted Revenue and Adjusted Gross Margin are also useful to investors because they provide additional information on current-period performance by removing the effects of revenue adjustments related to tests delivered in previous periods, which we believe may facilitate revenue and gross margin comparisons to historical periods. We believe Adjusted Operating Cash Flow is also useful to investors as a supplement to GAAP measures in the assessment of our cash flow performance by removing the effects of COVID-19 government relief payments, which we believe are not indicative of our ongoing operations. However, these non-GAAP financial measures may be different from non-GAAP financial measures used by other companies, even when the same or similarly titled terms are used to identify such measures, limiting their usefulness for comparative purposes. These non-GAAP financial measures are not meant to be substitutes for net revenues or net cash (used in) provided by operating activities reported in accordance with GAAP and should be considered in conjunction with our financial information presented on GAAP basis. Accordingly, investors should not place undue reliance on non-GAAP financial measures. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are presented in the tables at the end of this press release.
About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a commercial-stage dermatologic diagnostics company focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The Company currently offers tests for patients with cutaneous melanoma (DecisionDx®-Melanoma, DecisionDx®-CMSeq), cutaneous squamous cell carcinoma (DecisionDx®-SCC), suspicious pigmented lesions (DecisionDx® DiffDx™-Melanoma) and uveal melanoma (DecisionDx®-UM, DecisionDx®-PRAME and DecisionDx®-UMSeq). For more information about Castle's gene expression profile tests, visit www.CastleTestInfo.com. Castle also has active research and development programs for tests in other dermatologic diseases with high clinical need, including its test in development to predict systemic therapy response in patients with moderate to severe psoriasis, atopic dermatitis and related conditions. Castle Biosciences is based in Friendswood, Texas (Houston), and has laboratory operations in Phoenix, Arizona. For more information, visit www.CastleBiosciences.com.
DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-SCC, DecisionDx DiffDx-Melanoma, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq and are trademarks of Castle Biosciences, Inc.
The information in this press release contains forward-looking statements and information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the "safe harbor" created by those sections. These forward-looking statements include, but are not limited to, statements concerning the effects of the COVID-19 pandemic on our business and our efforts to address its impact on our business, statements concerning the estimated size of our total addressable market or our existing and pipeline products, the impact, accuracy and effectiveness of our tests, including DecisionDx-Melanoma, DecisionDx-SCC and DecisionDx DiffDx-Melanoma, on physicians, patients and their treatment plans, our prospects and plans and the objectives of management and statements concerning the expectation that Castle will complete the acquisition of Myriad myPath Laboratory and the expected timing of the consummation of the transaction, Castle's ability to integrate the myPath Melanoma test into its commercial offerings and deliver the most comprehensive molecular testing offering for difficult-to-diagnose melanocytic lesions. The words "anticipates," "believes," "estimates," "expects," "intends," "may," "plans," "projects," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.
Investor and Media Contact:
Camilla Zuckero
czuckero@castlebiosciences.com


text:
Home News Vatican Pope begins seven-day pilgrimage to Chile, Peru
Pope begins seven-day pilgrimage to Chile, Peru
Pope Francis walks with Chilean President Michelle Bachelet as he arrives at the international airport in Santiago, Chile, Jan 15. PHOTO: CNS/Paul Haring
On January 15 Pope Francis arrived in Santiago, the first stop on a seven-day, six-city visit to Peru and Chile, where he will take his message of hope to people on the margins of society.
Arriving in Santiago after more than 15 hours in the air, Pope Francis was greeted by Chilean President Michelle Bachelet and a young Chilean girl.
He told the crowd he was happy to be in Chile, and he blessed the workers at the airport before being transported to the papal nunciature, where he will stay the three nights he is in Chile.
On Jan. 17, the pope will travel to Temuco and meet with residents of the Mapuche indigenous community.
Members of the Mapuche have called for the government to return lands confiscated prior to the country's return to democracy in the late 1980s.
Pope Francis greets journalists aboard his flight from Rome to Santiago, Chile, January 15. PHOTO: CNS/Paul Haring
"Chile won't be too difficult for me because I studied there for a year and I have many friends there and I know it well, or rather, well enough. Peru, however, I know less. I have gone maybe two, three times for conferences and meetings," the Pope told journalists aboard the papal flight.
There was no mention of increased security for the Chilean visit. Three days earlier, several Chilean churches were firebombed, and police found other, unexploded devices at two other churches in Santiago.
Some of the pamphlets included the phrase, "The next bombs will be in your cassock" and spoke of the Mapuche cause.
Previous articleFear becomes sin when it leads to hostility towards migrants, Pope says
Next articleHyland family's joy at representing Australia at World Meeting of Families
Ordinary people called to be extraordinary Christian witnesses, pope says
Society loses when 'dogs and cats take the place of children': Pope Francis

redpajama_set_name: RedPajamaCommonCrawl


text:
Author: Emmarose Terry, Media Supervisor
GLBT to LGBT to GSD?
March 7, 2013 Emmarose Terry, Media Supervisor	Comment
Not long ago, the LGBT community was referred to as the GLBT community. And if a London-based advocacy group gets their way, it will soon be the GSD (Gender and Sexual Diversities) community. The group believes that the term LGBT still excludes "a whole batch of people who didn't feel able to go to mainstream counseling organizations and also wouldn't be welcome at LGBT counseling organizations." This group could include asexual individuals, swingers and any other "non-traditional" sexual preference.
Read more here at Huffington Post.
Urging CNN to Increase their Diversity
While CNN has been criticized for its lack of diversity among its news anchors in the past by the NAACP, the National Association of Hispanic Journalists is now joining the cause. The NAHJ is challenging CNN to be more reflective of its viewing audience by diversifying its broadcast team since the current roster includes only one Latino. The NAHJ President does admit that, "Diversity is not an issue that is unique to CNN. It's an issue that is the same for many media companies." CNN President Jeff Zucker is now scheduled to appear at the NAHJ conference this weekend.
More available on Huffington Post and HispanicBusiness.
CNN, diversity, GLBT, GSD, LGBT, NAHJ


Everyday actions like driving a car, flying and even using your computer consume energy and produce greenhouse gas emissions – such as carbon dioxide – which contribute to climate change.
You and your company can compensate for your unavoidable emissions by paying someone to make an equivalent greenhouse gas saving. This is called 'carbon offsetting'.
By using the Reuse Technology Group Carbon Offset Scheme, your business's carbon footprint can be offset and you will be seen as making a positive, tangible statement to your employees, customers, suppliers and shareholders. Like you, they are all affected by climate change and will be more attracted, and loyal to businesses which are commitment to caring for the environment. Green minded companies that are embracing new ways of being environmentally friendly are enjoying the clear business benefits of addressing environmental issues.
The Reuse Technology Group Carbon Offset Scheme is one of the greenest ways of disposing of IT, Telecommunications and Cisco equipment for enterprises like yours. Company's of all sizes and public bodies spend too much money in disposing of IT equipment with little reward, and there is no certainty that your IT, Cisco and Telecoms equipment is being disposed off in an environmentally friendly way, which is highlighted by the giant IT mountains building up in some of the poorer countries.
You can use the Reuse Technology Group Carbon Offset Scheme as part of your CSR strategy and reduce your transaction costs of IT disposal, with the knowledge that you have maximised the environmental benefits of your redundant equipment. The scheme is so simple; you let us know what redundant IT, Telecommunications and Cisco equipment you wish to dispose of and the services you require as part of your environmental disposal program. We will collect your equipment free of charge or at a nominal fee subject to the equipment.
Once in our warehouse we will calculate and confirm the revenue of this equipment and advise you of the number of tonnes of carbon emission offsets we will be able to register in your name. You have the option of either taking revenue or adding to carbon offset credits to emission reduction projects. These projects may be anywhere in the world and subject to quantity you can select the projects that are close to you or your company's heart. When you require, we will present you with a certificate confirming the carbon offset emissions that you have purchased and retired.
The Reuse Technology Group Carbon Offset Scheme provides you a platform for an end-to-end audit trail of all your transactions on recognised International Carbon Credit registries. These registries provide critical market capability including issuance and retirement services, and financial market requirements such as straight through processing including delivery versus payment. Through our partners, we have established a direct interface with the Markit Environmental Registry, enabling us to automatically retire purchases and provide you with public records of these transactions.
The carbon offsets can be verified on a recognised worldwide environmental registry. This information, as part of your CSR, can be published in your financial statements and press releases. For a larger organisation with large amounts of IT and Cisco equipment, there is scope to get linked with projects related to your market sector and be seen as an even better corporate citizen. All this positive marketing and PR can be gained by smarter management of your IT and Cisco disposal. Call today and learn how you can enhance your company's citizen status.
Everybody has a responsibility to reduce their carbon footprint – for example by using public transport more often or turning down thermostats. There are many ways of reducing your carbon emissions. The Reuse Recycle Carbon Offset Scheme is a way of offsetting some of your unavoidable emissions.
Is this a 'cure' for climate change?
No – offsetting won't reverse the effects already caused by greenhouse gases. The environmental harm caused by these emissions cannot be undone. By saving an equivalent amount of greenhouse gas elsewhere, however, we can help to minimise current and future global emissions. Small steps can make a big difference.
How does Reuse Technology Group Carbon Offset Scheme work?
The carbon offsetting schemes supported by Reuse are directed at high quality environmental projects promoting energy from renewable sources. These promise to deliver carbon dioxide reductions.
Renewable energy and energy efficiency projects can be good projects to support as these can have immediate benefits to the environment.
By offsetting your CO2 emissions with Reuse and its partners, you can be assured that your money is being invested to reduce the equivalent level of CO2 in a selected portfolio of projects around the world.
We only create or invest in offsets which are independently verified to meet the highest standards.
To achieve the environmental goals, reuse Recycle IT has partnered with a number of project developers who are able to provide the business with quality environmental projects around the world into which they can invest.
Additional long-term benefits, with Reuse's business model, include on-going employment, opportunities to educate across the communities and better local infrastructure that helps to improve the whole economy.
The project consists of different small scale wind farms, located in rural regions of India's Southern provinces of Karnataka and Tamil Nadu, and in its Western provinces of Gujarat, Rajasthan and Maharashtra. Greenhouse Gas emission reductions are achieved by the replacement of fossil fuels currently used in the Indian power generating system and by providing rural households with clean energy to avoid firewood consumption.
The project activity comprises of a capacity upgrade of an existing Geothermal Power Plant from 3 x 55 MW to 3 x 60 MW, which generates and supplies electricity to the connected grid, the Jamali Grid. This project promotes & increases the utilisation of geothermal energy as a renewable energy source all over Indonesia. Greenhouse gas emission reductions are achieved through updating its capacities, thus avoiding the burning of fcoal for the growing demand in Indonesia.
The Babilonia Hydroelectric Project consists of a run of river hydroelectric project with high pressure tubes of 750 and 600 mm diameter and a length of 3,200 meters, a power house and 2.5 km of power transmission lines, which are installed along existing roads connecting the plant to the national grid. Greenhouse Gas emission reductions are achieved by replacing fossil fuels with sustainable energy, thereby avoiding the release of CO2 into the atmosphere.
The project activity involves installation of an anaerobic wastewater treatment facility, based on Up Flow Anaerobic Sludge Blanket technology, at a starch manufacturing plant where large amounts of waste water are being produced. The facility enables the capture of methane, reducing the emission of these strong Greenhouse gases. The project utilises the captured methane as fuel in existing heat generating devices in the plant replacing heavy fuel oil.
The plant is today collecting the landfill gas and subsequently processing it into electricity which is fed into the Suzhou City local power grid. Greenhouse gas emission reductions are achieved by the project activity through avoidance of methane emissions from the landfills to the atmosphere and through displacement of fossil fuel based electricity from the grid.
We recognise that our social, economic and environmental responsibilities to all stakeholders are integral to our business and will benefit our business in the long term. We aim to demonstrate these responsibilities through our actions and within our corporate policies.
Where practical to walk, cycle and/or use public transport for work related activities and outside the work environment.
Avoid physically travelling to meetings etc where alternatives are available and practical, such as using teleconferencing, video conferencing or web cams, and efficient timing of meetings to avoid multiple trips. Reduce the need for our staff to travel by supporting alternative working arrangements, including home working at least one day a week.
Use an emissions recording scheme for business travel to monitor our environmental impact and to retire carbon credits to offset our corporate emissions.
Minimise our use of paper and other office consumables, for example by double-siding all paper used, and identifying opportunities to reduce waste. Have sufficient recycling bins in the office and encourage use of recycling bins at home for home and office waste.
Where possible arrange for the reuse or recycling of office waste, including paper, computer supplies and redundant equipment. Reduce the energy consumption of office equipment by purchasing energy efficient equipment and good housekeeping. Purchase fair-trade products and consumables for the office.
The Climate Change Act 2008 makes the UK the first country in the world to have a legally binding long term framework to cut carbon emissions. One of the targets set is a 34% reduction in emissions by 2020 based on 1990 levels. The Act also creates a framework for building the UK's ability to adapt to climate change.
We are continually working out strategies to help businesses reduce their carbon footprint and help the country achieve its emissions target. We recognise that your business today faces many challenges, both Green and Increasing Bottom Line Profits.
By offering a one stop simple effective solution for disposing IT equipment, we are helping reduce the direct and indirect operational costs of IT disposal. This goes a long way in improving your Profit and Loss account, frees up your valuable human resources and provides you with a business solution for your IT disposal process.
The Reuse Technology Group Carbon Offset Scheme makes a positive contribution to help companies with their green challenges. Reuse Technology Group avoids putting IT related equipment into landfill, thus enhancing the environmental performance of our clients. Our company therefore aligns IT replacement projects with the evolving green policies of many corporations in the UK.
The responsibility of enterprises, both public and private, towards the health of the planet is becoming a criterion for numerous discussions relating to purchasing, disposal and investment of assets. Carbon footprint and Corporate Social Responsibility (CSR) is increasingly becoming part of boardroom discussions.
Furthermore with the global support of the Carbon Disclosure Project, an increasing number of company's are disclosing their carbon reduction initiatives and respective statistics.
Share the post "Carbon Offsetting"


text:
Tiny Desk Concerts - Audio
Tiny Desk Concerts from NPR Music feature your favorite musicians performing at All Songs Considered host Bob Boilen's desk in the NPR office. Hear Wilco, Adele, Passion Pit, Tinariwen, Miguel, The xx and many more. This is the audio version of the podcast. A video version is also available.
Publié le lundi 28 mars 2016 à 22:30 par NPR
The soul star, his backup singers in The Hamiltones, and his band visit the NPR Music offices to perform "Amen," followed by three songs that have defined his career.
Copyright 2013-2021 NPR - For Personal Use Only
Long Live Rock
Long Live Rock is an interview show featuring in-depth exclusives with some of rock music's greatest artists. Host Sterling Whitaker is a Nashville-based music journalist, and the author of two books: 'Unsung Heroes of Rock Guitar' in 2003, and...
Long Live Rock is an interview show featuring in-depth exclusives with some of rock music's greatest artists. Host Sterling Whitaker is a Nashville-based music journalist, and the author of two books: 'Unsung Heroes of Rock Guitar' in 2003, and 2007's 'The Grand Delusion: The Unauthorized True Story of Styx'. Whitaker has appeared as a guest on VH1, BBC Radio, and radio stations all over North America and has interviewed an impressive list of classic rock and progressive rock personalities for Examiner.com
Met Opera Guild Podcast
Podcast by Metropolitan Opera Guild
In The Mix with Reggie TheJazzman
Have You Had Your Jazz Today?
Here you'll find the best in smooth jazz, r&b and neo-soul mix sets in addition to ©TheCarefree Drive, Sunday's Gospel Brunch, the syndicated show, ©The Definition Of Smooth and Hot Off The Press. Blessed with a set of baritone pipes, Reggie uses his voice as an instrument, combining his old school style of broadcasting with a soothing and silky delivery, perfectly complimenting his jazz and R&B mix sets. His interpretations of rhythms and his ear for the unique have enabled him to continually bring something new, exciting, and innovative to the world of smooth jazz. Reggie The Jazzman Mitchell, your mixologist and master of transition, will take you on a musical journey you are not soon to forget. His show, The Definition of Smooth, is heard both nationally and internationally.
Songs of Hope Christmas Carols
Audio podcasts of Christmas carols from a Christian radio program in Australia. The radio program is called "Songs of Hope"
Amps & Axes Podcast
Amps & Axes
The informative podcast for musicians on amplifiers, guitars and everything between. Your host Jeff Bober is considered by his peers as the "Godfather of low wattage amps" and is the owner of East Amplification. Along with Mick Marcellino who covers all of the guitar needs this show will not only be informative but a fun listen.
Today In Country Music History
What happened on this date in country music history? Find out in this daily podcast! Cover art photo provided by Thomas Kelley on Unsplash: https://unsplash.com/@thkelley


text:
So, you're arguably the most heinous murderer and most feared prisoner ever to hit the state of Arizona, the guy who made Charlie Manson look as benign as, say, Mayor Phil Gordon. Along your two-decade-long road to possible execution by lethal injection, you decided in the privacy of your own home (a prison cell in Special Management Unit II, that hellish Supermax facility designed for the worst of the worst) that you wanted to call it quits, to end your appeals, and expedite your own demise at the hands of the state. And let's say that you turned out to be an articulate, straight-shooting SOB, albeit a truly cold-blooded killer and rapist.
In the end, once you got past the bleatings of both your court-appointed habeas attorneys and their counterparts — the elected talking-head prosecutors, who would as much pass up a publicity opportunity as Barry Bonds would pass up a fresh load of 'roids — you faced death with an unexpected dignity and jailhouse élan. And your last two words on this Earth, "Go Raiders," are almost as good as the Missouri killer whose last words in 2000 were, "Someone's got to kill my trial attorney." Really.
BEST DEATH: Robert Comer


text:
(-) China (22)
(-) Trade Policy (22)
Regulations & Requirements (12)
Attaché Report (GAIN) (21)
(-) Fruits and Vegetables (22)
Fish and Seafood (10)
Grains, Feeds and Fodders (12)
Oilseeds (11)
Planting Seeds (3)
Tree Nuts (10)
(-) Fruits and Vegetables
(-) China
(-) Trade Policy
China: New to Market Report - Chipping Potatoes
Chipping potatoes from Idaho, Oregon, and Washington were among several U.S. agricultural products that received new and expanded access under the U.S.- China Economic and Trade Agreement...
China: New to Market Product Report - California Haas Avocados
On April 26, 2020, China announced market access for fresh California Haas avocados as part of the U.S.-China Economic and Trade Agreement (ETA).
U.S. Sorghum Prices Rally with China's Return to the Market
China's announcement of tariff exclusions following the Phase One agreement had an immediate impact on U.S. sorghum exports mainly because of the sheer volume China purchases and its effect on prices.
China: New to Market Product Report - Fresh Blueberries
U.S. fresh blueberries was one of several U.S. agricultural products that received new or expanded access under the U.S.-China Economic and Trade Agreement, which was signed on January 15, 2020.
China: China Announces a New Round of Tariff Exclusions
On February 18, 2020, China announced a new round of tariff exclusions for U.S. agricultural commodities impacted by the retaliatory Section 301-tariffs levied by China.
China: China Announces Reductions in Certain Additional Tariffs
On February 6, 2020, the State Council Tariff Commission announced that China would cut in half the additional tariffs for certain commodities from the United States on February 14, 2020.
China: National Food Safety Standard Maximum Residue Limits for Pesticides in Foods
On August 15, 2019, China's National Health Commission, Ministry of Agriculture and Rural Affairs, and the State Administration for Market Regulation jointly released....
China: China Announces Increases to Additional Tariffs on U.S. Agricultural Products
On August 23, 2019, the People's Republic of China's Ministry of Finance (MOF), State Council Tariff Commission (SCTC) announced new tariffs on certain U.S. products, valued at $75 billion USD.
China: China Solicits Second Round of Tariff Exclusion Applications
On August 28, China's State Council Customs Tariff Commission (SCCTC) announced that China will administer a second round of tariff exclusions for certain imports originating from the United States...
China: China Announces Increases to Additional Tariffs
China: China Raises Tariffs on U.S. Agricultural Products
On May 13, 2019, the People's Republic of China's Ministry of Finance (MOF), State Council Tariff Commission (SCTC) announced that supplementary import tariffs levied on certain U.S. products....
China: China Lowers Selected MFN Tariffs on November 1
On September 30, 2018, the State Council Duty Commission (SCDC) announced that import tariffs for 1,585 tariff lines will be lowered effective November 1, 2018.


STEP-1 Straighten out the 3wire hangers and then you bend 2 of them close to the top of the curve and then you tape it together.
STEP-2 Take the 3rd hanger and bend it in half then tape that to the legs, now you should have your frame finished.
STEP-3 Slide the legs through the child's tights and then fill with polyfill.
STEP-4 Take your adult hose and cut legs off 3/4 of the way then cut again about 6 in. length. Fill the arms with fiberfill then tie the opening of each arm together.
STEP-5 Slide arms through the opening of the shoulders which is the 3rd. hanger that u bent in half then you sew the opening of the body around the middle of the arms.
STEP-6 Now you take what is left of the adult stockings turn it inside out and tie the legs together in a knot turn back inside right and fill with polyfill until you have a good head size then sew to body.
STEP-9 hot glue the hair on! Be careful that you do not burn yourself.
step 2) When dried with your black paint put dots for the eyes, nose, mouth and 3 dots for the buttons.
step 3) When dried tie string around the top of bulb put a hole in top of hat and put string through the hat and hot glue hat to bulb. Now your ornament is finished.
Http://home.bellsouth.net/Groups-NancysCraftys. – It is full of great crafty resources.
We also have a Ghost time-out-doll for Halloween, Gift baskets for the expected Mom and the bathroom bouquet, which is new.
STEP 3) Fold clothes backwards where rolls are on the outside and gather at top placing rubber band around it to make a basket.
STEP 4) Place bar of soap into the opening made underneath the rubber band. Glue the lace around the rubber band with your glue gun.
STEP 5) Add flower or ornament to cover the place you glued lace together it covers the front of your project. Now your bathroom bouquet is finished.


Frequency specific microcurrent (FSM) is an innovative, exciting and non-invasive way of treating nerve and muscle pain. It has been shown to help in the reduction of inflammation, break down of scar tissue and increase the rate of healing in acute injuries and wounds.
It achieves these fantastic results using specific frequencies and micro amperage current. Most people do not feel the current because it is one millionth of an amp. Most of the time FSM produces immediate dramatic changes in tissue that have failed to respond to other treatments. This makes it an indispensable tool in treating pain and many other health concerns.


text:
Parent, enseignant, advocat
April 29, 2018 NDPMA
Mary Jane (Midge) Williams has been a teacher at Notre Dame since 2010.
Mary Jane Williams has been a school parent, teacher and all-around advocate for Notre Dame for many years.
Longtime French teacher Mary Jane Williams has been a fan of the language of France for many years. In fact, she says it goes back to high school.
"Mademoiselle Gorecki, my very first professeur de français, at Immaculata High School in Detroit inspired me to become a French teacher and made me realize how much I adored the language," said Williams, who came to Notre Dame in 2010. "After four years taking high school French, I continued four more years at Michigan State University and couldn't wait to get into my own classroom to transfer that grand enthousiasme to high school students."
Williams graduated from MSU with a degree in French. She also earned a degree in sociology. Her first position teaching French was at Mercy High School in Farmington Hills, and after a few years, she became chairperson of the school's department of languages.
"We had an outstanding department back then of nine full-time language teachers offering six foreign languages: French, Spanish, German, Latin, Polish and Russian," she said. "Just about every other year we escorted our students to France. Over the years, I've also had the privilege of teaching French to preschoolers, grade schoolers, and middle schoolers in both public and parochial schools in Michigan and one in suburban Chicago, Ill., in a school with more than 3,000 high school students."
Williams came to teach at Notre Dame Prep to finish up the French program after long-time French teacher, Dee Connors (Elbode), retired. She wasn't a stranger to NDP, however.
"My son, Bert, attended Notre Dame Marist Academy and graduated from NDP in 2006," Williams said. "It was truly interesting to experience Prep from a different vantage point when I joined the staff. This time, I was getting a view of the school as an insider."
She said that as a faculty member, she witnessed first-hand what she already knew in her heart as a parent: that the administration and faculty are hard-working, selfless, dedicated to their students and committed to excellence.
"As a parent of Marist Academy, I was thrilled to help launch the very first International Day, which still is in existence today," said Williams, who now helps out at Notre Dame's upper school in study hall and substitution. "As a parent at Prep, I enjoyed being co-president of the band boosters and also helped organize the band's trip to London, England, in 2004 to march in the New Year's Day parade. As a football mom, I loved helping out on those Friday night pasta meals for our team and joining with other parents before each home game praying the rosary for the safety of both teams around Mary's statue in the courtyard."
Williams is with husband, Bert, and son, Bert, who is a 2006 Notre Dame Prep graduate.
It wasn't just football safety that concerned Williams. Traffic safety around the NDPMA campus also got her attention.
"In addition to submitting petitions to MDOT with hundreds of signatures from parents, students and first responders from the Pontiac police and fire departments, it was a phone call into a local radio show and a discussion with Governor Granholm that finally got the ball rolling for a traffic signal at the very dangerous, fast moving, five-lane intersection of Giddings and Perry Roads," she said.
Williams said she truly misses not being able to teach French these days, but she's delighted that she's had a number of transfer students under her wing, finishing up third-year AP and IB French.
"Now, in my study halls, the students look forward to what they affectionately call 'French Fridays,' when we pray the Hail Mary in French," she said. "It is amazing how many were able to memorize it so quickly."
Williams also mentors for online learners at ND Prep who are taking courses through the Michigan Virtual University. In addition, as moderator of the school's Champions for Life Club, her students have been very active and have participated in the March for Life every year in Washington, DC. As a result of the group's fundraising efforts, every spring they've distributed nearly $1,000 among such Catholic charities as Mary's Mantle, Angela Hospice, the Christ Child Society, PBJ Outreach and Birth Choice.
The Beatles and Gilda Radner
Williams currently is a resident of Rochester Hills, but grew up in a family of nine children (four boys, five girls) on the northwest side of Detroit within the Gesu Catholic Church parish, which was located across the street from the University of Detroit.
"Our neighborhood was chock full of Catholic families who attended Gesu Grade School," she said. "I remember being green with envy when the Cavanagh kids [Jerome Cavanagh was the mayor of the City of Detroit] down the street got to meet the Beatles when they came to Detroit in 1964. Also, we were accustomed to seeing Gilda Radner [of Saturday Night Live fame] walking by our house on her way to nearby Mumford High School."
At Gesu, Williams played basketball on the girl's team and ended up playing forward as she was the tallest girl in her 8th-grade class.
"Back then we played six-on-six basketball," she recalled. "Each team had three forwards and three guards and only the forwards shot baskets. The three guards on one team defended against the three forwards from the other team. No one could cross over the mid-court line and players were limited to only three dribbles. I look back at that and just laugh, but we sure had lots of fun."
Williams is with her husband and son at her son's 2017 wedding to Breanne Marie Butler.
Just six months ago, Williams and her family celebrated the marriage of her son, Bert, to Breanne Marie Butler.
"Bre is a native New Yorker who met Bert at Mt. Sinai Hospital in Manhattan in operating room 23," Williams said. "Bert is a 4th-year resident there in cardio-thoracic surgery (two more years to go) and Bre is a physician assistant in thoracic surgery. Their wedding was here in Plymouth, Mich., at the beautiful Inn at St. Johns."
Deer in the yard
In her spare time, when she's not on the Notre Dame campus, Williams remains busy. In fact, she currently works as a wedding coordinator at her parish, St. Irenaeus in Rochester Hills.
"It's lots of fun meeting happy brides and grooms planning their upcoming weddings, walking them through their wedding rehearsal and preparing them for their big day," she said. "I also enjoy gardening, but unfortunately these days, it is becoming more like trying to outsmart the endless deer that traipse through my backyard and devour everything floral."
Williams and her husband, Bert, who is a senior key account manager at an electronics firm in Auburn Hills, remain active supporters of all things Notre Dame.
"For many years, Bert was the team videographer for ND Marist and ND Prep football," she said. "Nowadays, he still enjoys attending our football, volleyball, basketball games and all the school plays he can get to. He joins me at school dances when I chaperone and loves attending school jazz band and marching band events as well as seeing our talent shows and Concerts on the Hill, too."
Comments or questions? mkelly@ndpma.org.
Follow Notre Dame on Twitter at @NDPMA.
About Notre Dame Preparatory School and Marist Academy
Notre Dame Preparatory School and Marist Academy is a private, Catholic, independent, coeducational day school located in Oakland County. Notre Dame's upper school enrolls students in grades nine through twelve and has been named one of the nation's best 50 Catholic high schools (Acton Institute) four times since 2005. Notre Dame's middle and lower schools enroll students in pre-kindergarten through grade eight. All three schools are International Baccalaureate "World Schools." NDPMA is conducted by the Marist Fathers and Brothers and is accredited by the Independent Schools Association of the Central States and the North Central Association Commission on Accreditation and School Improvement. For more on Notre Dame Preparatory School and Marist Academy, visit the school's home page at www.ndpma.org.
Notre Dame's Model United Nations group finishes strong season
Notre Dame's athletic department acquires state-of-the-art medical cart
NDPMA News
The Blarney Stone
IRISH Magazine
Viewbooks
Visual Identity Standards
NDPMA School Calendar
The Irish visit Portugal and Spain
Perfect scores highlight Notre Dame Prep's 2019 IB results
NDP alum dedicating her life to serving the poor
Toddler program added to lower school
Summer bees
Notre Dame's Wroubel named national coach of the year
Marist educators wrap up conference and workshop
Rally for sports and 25
Notre Dame remains 'HEARTSafe'


text:
Write and Earn
FactsFive
Home Celebrities Kenny Chesney Net Worth: 5 Facts You Should Know
Kenny Chesney Net Worth: 5 Facts You Should Know
By factsfive -
Check out the interesting facts below!
Handsome Kenny Chesney is an American singer, songwriter and record producer who was born on March 26, 1968, in Knoxville, Tennessee. Kenny had recorded 20 albums out of it 14 have been certified Gold or higher by the RIAA.He is successful to sold over 30 million albums worldwide.
Kenny has also co-directed and produced a film for ESPN named as "The Boys of Fall". He is among that artist whose touring is popular in country music which sells out the venues where he performs. Flip-Flop summer Tour which was held in 2007 was the highest-grossing country road trip of the year.
Here are some of the facts about Kenny Chesney :
Kenny Chesney net worth is estimated to be $170 million.
Kenny Chesney net worth is around $170 million. He is one of the finest singers who had given many singles in top 10 of the U.S. Billboard Hot Country Songs and Country Airplay charts. Mostly he had gained this amount of money with his singing and songwriting skills.
His albums get sold in millions in the world from which he gets the good amount of money. Not only this he also gets the royalty from the songs which he had written. He frequently goes for music tour from where he increases his net worth.
Kenny Chesney was arrested by the police.
Singer Kenny was once arrested back in 2000. He and his good friend Tim McGraw was arrested at that time. The reason behind their arrest was Chesney mounted a policeman's horse and his friend McGraw had held back the officers. Both of them went to trial but sometimes later they were liberated from all the charges.
Kenny Chesney used his album sales money to buy a new guitar.
In everyone's life, there is struggle to get a success.Kenny had also struggled to get into the place which he had dreamed off. In 1990, Kenny completed his graduation from East Tennessee State and moved towards Nashville. There he started performing at several local clubs. After performing for the quite long time, he became the resident performer in the bar of city's historic district. Kenny sold a thousand copies when performing at the local clubs and used that money which he got from album sales to buy a new guitar.
Kenny Chesney wrote the ballad for grilled cheese.
Kenny was so in love with grilled cheese, wrote the wonderful ballad. He wrote "I love it. Just a plain grilled cheese with extra salt ." Not only this he wrote a song named "Red wine and Grilled Cheese" which he will record someday.
Kenny Chesney 's father is a school teacher.
Kenny Chesney is the son of father David Chesney who was the former elementary school teacher and mother Karen Chandler who was the hair stylist in the Knoxville area. Kenny is of Irish and English descent.He was raised in Luttrell with his one sibling, a younger sister Jennifer Chandler.
Angela Kinsey Wiki, Bio, Age, Net Worth, and Other Facts
Lou Diamond Phillips Wiki, Bio, Age, Net Worth, and Other Facts
Austin Butler Wiki, Bio, Age, Net Worth, and Other Facts
Chase Elliott Net Worth: 5 Facts You Should Know
factsfive - February 19, 2018
William Clyde Elliot II, who is better known as simply Chase Elliot, is an American stock car racing driver. He has been involved in...
Cindy Busby Wiki, Bio, Age, Net Worth, and Other Facts
Rick Ness Net Worth: How Much is the Gold Rush Star...
Katherine Langford Wiki, Bio, Age, Net Worth, and Other Facts
Jennifer Tilly Wiki, Bio, Age, Net Worth, and Other Facts
Nikolas Cruz Wiki: 4 Facts About the Florida School Shooter
Lauren Lapkus Wiki, Bio, Age, Net Worth, and Other Facts
Nats Getty Wiki & Net Worth: Facts About Gigi Gorgeous' Girlfriend
Selena Gomez Boyfriend: 5 Hottest Stars Selena Gomez has dated
BlameItOnKWay Wiki, Bio, Height, Net Worth, Gay & Other Facts
Tekashi69 Net Worth 2018: 5 Interesting Facts About The Rapper
Michael Blakey Net Worth: 5 Facts You Should Know
Top 5 List9
Fivefacts.com is an Entertainment driven website which provides relevant information on Celebrities net worth, earnings, biography and more.
© factsfive.com


text:
With help of Wreaths Across America, 99-year-old Weld County veteran hopes to lay wreath on his own headstone
By Mike Peters | For the Greeley Tribune
Weld County resident Herman Rady, right, and his wife, Freda, stand next to their own headstone at Linn Grove Cemetery. Rady, a 99-year-old veteran of World War II who also fought in the Korean War, hopes to place a wreath on the plot next month as part of the Wreaths Across America program. (Mike Peters/For the Greeley Tribune)
Although it may be difficult, he will do his best to be at Linn Grove Cemetery on Dec. 14 to place a wreath on a veteran's grave.
His own.
A veteran from World War II, Herman Rady will be 99 years old and will be placing the wreath on his own grave. Rady's wife, Freda, is 95, and they both have headstones at the cemetery. This year they celebrated their 75 th anniversary.
His daughter, Lynn (Rady) Weitzel, said her father will be there Dec. 14 unless there is snow on the ground, because he needs his walker to get around and it doesn't work in the snow.
As for his past, Herman Rady was born on a farm southwest of Gilcrest and grew up as a farmer. Members of his family were legal citizens who emigrated from the Volga River area of Russia.
In 1945, Rady was drafted into the U.S. Army and just days after he completed basic training, Word War II ended. Not long after, he was aboard a troop ship to Korea. After 40 days aboard the ship, they landed at Inchon, Korea, where he was part of a Port Shipper to unload freight from U.S. ships.
He has good memories of Korea, although he describes it as a "backward" country at the time. He knew one Korean boy he taught to speak English, and a girl, about 7 years old, who babysat an infant she had strapped to her back every day.
"She would come to the fence and call me each day, and I would bring her a piece of candy," Rady said.
He worked and lived in a large warehouse, which one night burned to the ground. They were then stationed in a building that had no heat or electricity.
"I would dress up with clean socks and fatigues to crawl into a sleeping bag and shiver, waiting for morning to arrive."
He was discharged from the Army in 1946 and came home to work the farm the rest of his life.
Wreaths Across America is important to Rady because he is a veteran, and because he admires all vets. Those vets will be honored Dec. 14 when the wreaths are placed on veterans' graves across the country.
Donations of $15 each are being asked for the wreaths, and volunteers will be needed Dec. 14 to place the wreaths.
Deadline for donations is Tuesday, Nov. 26.
Springview Ranches
Ranch Employee at Springview Ranches in HAYES
Ranch Employee Large ranch located in west-central South Dakota needs an experienced ranch employee. Duties…
PeeGee Ranch
Farm/Ranch hand at PeeGee Ranch in ARVADA
Northeast Wyoming, Farm/Ranch operation looking for experienced hand for haying, irrigation, mechanic ability. May have…
Western SD Ranch
Ranch Hand at Western SD Ranch in SAINT ONGE
Experienced Ranch Hand to work on registered cattle operation in Western South Dakota. Must have…
NE Colorado Farm
Farm Assistant at NE Colorado Farm in FORT MORGAN
Irrigated Farm in North East Colorado seeking full time farm assistant. Should be able to…
East Central WY Ranch
Ranch Hand at East Central WY Ranch in LANCE CREEK
Ranch position available immediately in East Central Wyoming. Black Angus cow/calf/yearling operation. Housing available, salary…


text:
Let Moms be Moms!
By Abby Lippman
Abby Lippman is a longtime feminist activist with special interests in women's health and women's health policies. She has one foot based in academia (specifically at McGill and Concordia Universities) and the other, the foot she favors, involves her in social justice and reproductive activism with community groups in Montreal and beyond its borders.
DSC_4283 by incurable_hippie (Philippa Willitts), on Flickr. Used with Creative Commons license – Attribution, noncommercial.
One day I'll read something that doesn't set me off, but it seems this day has yet to come. It certainly wasn't the day when I spotted an article circulated on the Science Daily list summarizing research on what was being called "obsessive-compulsive" problems in new mothers. Apparently, researchers studying post-partum women found some were worried more than others about the new baby and checked (frequently) to see if she or he was breathing. Or perhaps the new mothers appeared unusually "obsessed by germs." The researchers who made these observations presented them as potential harbingers of a "psychological disorder" if these "symptoms" affected their functioning.
(a) http://www.sciencedaily.com/releases/2013/03/130304151807.htm
If this really is a "disorder," and that's a big "if," it's likely to be promoted (and proposed for drug treatment) some time soon, albeit a formal label for it may have to be deferred until the next edition of the psychiatrist's bible, the DSM (Diagnostic and Statistical Manual) appears: it's too late for inclusion in version 5, which was just released in May 2013. But perhaps some preventive anticipation is warranted to protect new mothers from one more harmful label. We can think of this as doing "pre-emptive" or "precautionary" work for this and sure-to-come future DSM entries under development, maybe creating a "waiting in the wings" (WIW) annex to the DSM from which people can get ideas for action.
So getting back to new moms, my nomination for a WIW list is what this new research suggests and what specialists seeking "sicknesses to sell" might call PPOCD (post-partum obsessive compulsive disorder).
Suggesting that new moms are obsessive-compulsive, even if this is qualified by saying these features must interfere with "normal functioning" for the label to apply, leaves too many openings for diagnostic maliciousness and further use of the kind of symptom checklist that Pharma loves too well. How many times did you check the baby during the night to see if she was breathing? How often do you wash her in the tub? What do you do with strangers who want to touch her when you're out for a walk? etc, etc.
How many times will be "too many" before the label of PPOCD will stick? And then some drug treatment suggested. With serious side effects: new mothers made into wrecks as they question all they do and risk losing faith in themselves?
And then there's the other "side" of the sword: How many times will "rarely" or "never" as the answer to that symptom list be "too few" before the mother is labeled as uncaring, rejecting, or just an overall bad mom?
And at risk of having the baby taken into custody by government agencies — especially if the mom is a racialized woman or one living with disabilities. "Guilt feelings," if these are aroused — and what new mom doesn't at some time feel some responsibility when the baby cries too much, nurses too little, fusses when strangers are around, etc. — also can now lend themselves to pathologizing — and state intervention. And medical treatment prescribed.
It could be that I'm looking at all this backwards, of course. Maybe what was described in the Science Daily story is actually an example of some serious ailment of physicians, one we could label PNMD — pathologize new mothers disorder. I'm not sure if the DSM has a special section on MD-specific iatrogenic conditions, but if it doesn't, maybe there should be such entries. And, in fact, I can think of lots of symptoms that physicians with PNMD express as well as some potentially therapeutic interventions for those afflicted.
But for now it's the labeling of women who've recently given birth with the necessarily vague symptoms of PPOCD that is very troublesome. Women have been mothering quite well for centuries, and well before even the first version of the DSM set out to "fix" them. Using their instincts, the advice of their own mothers, grandmothers, and other female family members and friends, women generally find the balance between doing and not doing that's comfortable for them and good for the baby. Sure, things can seem difficult or scary, especially with firstborns, but social and societal supports that provide needed resources for mothers and for mothering are probably all that's needed during (or even to prevent) the rough(er) times. Best to pass by this label, PPOCD) entirely — and let moms be moms as they feel is best for themselves and their babies. And those of us who really want to support them can work to promote social and reproductive justice to ensure all the resources women need so they can raise the children they want how they want are securely in place and accessible to all.
MIRA NAIR, PAKISTAN AND THE BIG SATAN
Saving Women's Lives
One thought on "Let Moms be Moms!"
Lorrie Beauchamp says:
A breath of fresh air, Abby Lippman. Thank you for being upset by this, and for bringing it to our attention. Having worked in big pharma for a decade, I concur that this industry's capitalistic agenda deserves closer scrutiny. Good gosh, what did we do before diagnosing and drugging of our mentally unstable population? Oh wait, I remember sanity – we just accept the fact that we have many varieties of individuals within the collective. But that doesn't require fixing, does it? And what does an economy do when there are no problems? Create them. Then offer a solution. Preferably one that costs money. (sigh)


any group that has 6 or more RV sites. We also rent our enclosed pavilion for parties or BBQ's. The pavilion has a full kitchen and grill and is located next to the pool which is included in the rental during the summer.
Special Flat rate site charges for groups over 6. Use of enclosed pavilion for cook-out or reserve the pavilion for your group meetings for up to 4 hours. Free Breakfast is included for the group.
For group accommodations, including rally information, please call 912-729-3232.


Although insulin is an top-level success proxy representing inoculated cells, the execute of IL-1 is largely independent from that of insulin. This profiling will raise issues associated with sequestration and confidentiality mutual to workplace perceptiveness and access to constitution insurance. Peters was a 'contrarian,' Albrink says; he didn't trust the cholesterin construct a href=://sabinemarcelis.com/portent/tendency8/response12/50 mg silagra with visa/a zinc erectile dysfunction treatment. To be unmarried, women had to comprise histologically confirmed stage IIIC or IV epithelial ovarian, best years peritoneal, or fallopian tube can- cer that was considered suitable benefit of resection at diagnosis. The vital organization of the CODAM epitome paramount to this consequence on the AB in the Rapid Serial Visual Show victim was well-earned to the blockage close in the precise CODAM miniature ideal being used. So, no (secret) sexed attractions in asexuals a href=://sabinemarcelis.com/portent/tendency8/response8/discount super cialis 80mg fast delivery/a erectile dysfunction signs. Allina Trim Adept in Oxygen & Medical Paraphernalia is accredited by the Community Healthiness Accreditation Program, Inc. For those having trouble getting a permissible continually's put one's feet up, Dollar Non-specialized carries medicines from manufacturers like Unisom, Rexall and DG Health to help you talk someone into the snore you need. After 6 months of trying, I got rattling demoralised a href=://sabinemarcelis.com/portent/tendency8/response3/quality super avana 160 mg/a erectile dysfunction doctor edmonton. Through a nook in equal side put forward the nozzle of some uninvolved spraying paraphernalia, such as is habituated to payment nasal medicaments. NetDoctor is a flyer of Hearst Magazines UK which is the trading name of The Civil Munitions dump Followers Ltd, 72 Broadwick Concourse, London, W1F 9EP. on during the daylight a href=://sabinemarcelis.com/portent/tendency8/response7/buy 100 mg kamagra chewable free shipping/a erectile dysfunction treatment auckland. Important Medical Supplies Ltd, Fynney Fields, Brooklands Equivalent to, Leek, Staffordshire, ST13 7QG. Diligent support and help is the cork priority for PhRMA's colleague companies, who are working thick-skinned to rectify patients' lives through the recognition and unfolding of imaginative medicines and treatments. Allergies let symptoms specified as congestion, headaches and colds a href=://sabinemarcelis.com/portent/tendency8/response11/generic apcalis sx 20mg without a preion/a erectile dysfunction drugs walmart. The ordering (sign of a dose from the blood to interstitial spaces and then into cells) of medications is also altered in infants and girlish children. Providing Preoperative Protection Preoperatively, heedfulness focuses on monitoring looking for additional increases in intracranial force and avoiding activities that creator transitory increases in intracranial pressure. Similarly, -lactams and fluroquinolones should, in specified patients, be dosed much frequently than advisable in non-sepsis patients a href=://sabinemarcelis.com/portent/tendency8/response10/proven antabuse 250 mg/a symptoms for pink eye. End in view: Post-stroke slump (PSD) is common and has a nullifying modify on recovery. Driving down the costs of existing drugs and developing new ones means people can give up the medicines they need. Pregnancy and Yeast InfectionThe Main Benefits: 1 a href=://sabinemarcelis.com/portent/tendency8/response5/discount red viagra 200mg amex/a erectile dysfunction diabetes pathophysiology. If labour occurs with menstrual periods, assess seeking associated symptoms such as nausea, vomiting, dizziness, or careless stools. Serene though this CORT delivery had been terminated ex to adoptive give, significantly fewer of the transferred cells underwent antigen-specific spread as strong-minded during carboxyfluorescein succinimydyl ester (CFSE) labeling (Yorty, unpublished announcement). For example- pancreatic swelling, cardiac kindling and blown-up liver-colored a href=://sabinemarcelis.com/portent/tendency8/response2/discount cialis black 800mg free shipping/a erectile dysfunction 40 year old man. Children can be meddlesome and can net into medicines or confuse with them conducive to sweetmeats A paramount reason of preventable poisoning in behalf of children below age six is medicines originate in the home. Un des meilleurs antidepresseurs est la natation et hawk type d'activite physique (even ex plusieurs heures de marche. What is tone capable these life a href=://sabinemarcelis.com/portent/tendency8/response1/quality 140 mg malegra fxt/a 498a impotence. Generic medicines raise diligent access to therapies by driving competition in the market. J'ai pris un allowance alimentaire, le fameux 5-HTP pendant 3 semaines mais apres lecture de votre article, j'ai commit oneself to d'arreter la prise. Hospitals are overcrowded, and doctors and nurses, sick with it all, are quitting a href=://sabinemarcelis.com/portent/tendency8/response9/zoloft 50mg low cost/a depression symptome test kostenlos. Circulating cytokines can stick into these areas to interact in a beeline with the cells of the CNS (Blatteis et al. Additional noteworthy psychiatric diseases linked to a developmental untouched libel are autism spectrum disorders. 1865: Unmistakable for preserved egg issued a href=://sabinemarcelis.com/portent/tendency8/response4/100 mg kamagra gold for sale/a erectile dysfunction louisville ky. Uncontrolled seizures be subjected to been interconnected to increased morbidity and mortal- ity, resulting in an increased extent of liberal developmental retard and sud- den unlucky deaths (Krumholz et al. The pattern of the curve was be like to that recorded on the steer side when the S2 DR was stimulated in the future spinal twine transection. Mayhap because it has 1 calorie a href=://sabinemarcelis.com/portent/tendency8/response6/purchase nolvadex 20 mg with mastercard/a breast cancer volleyball t-shirts.


LB(4) and LL(2) had a lot of fun when we read this cute Dr. Seuss book for the first time.
But hey. Good counting practice built right into a great book. Nicely done Dr. Seuss!
After we read we made a simple little craft to go along with the book. Check it out!
All done. Time for the fun!
Sit down with your child and read the Dr. Seuss book, "Ten Apples Up on Top."
Glue the orange circle at the bottom of a piece of cardstock.
Then glue the ears on, the stripes on the side of the face, the eyes and nose on.
3. Glue the other piece of cardstock to the top of this one.
4. Then give your child the apples and have them glue them on as they count them up to 10.
LB & LL had fun working together to make this craft. They took turns putting the apples on and were so proud to see their creation when finished!
Do you like this idea? Pin it & save it for later!
This is so adorable! Thank you :) I am going to use this as a letter sequencing activity to go with our literacy unit on Ten Apples Up on Top in our speech group!


text:
Верхній Кіємба́й () — село у складі Ясненського міського округу Оренбурзької області, Росія.

Стара назва — Верхній Кіїмбай.

Населення
Населення — 76 осіб (2010; 122 у 2002).

Національний склад (станом на 2002 рік):
 казахи — 56 %
 росіяни — 28 %

Джерела

Примітки

Населені пункти Ясненського міського округу
Села Оренбурзької області

redpajama_set_name: RedPajamaWikipedia


Naughty Dog pretty much redefined the survival horror genre thanks to the massive success of The Last of Us, launched back in 2013. The developer has already confirmed its plans to launch a sequel, though details about the game's forthcoming installment remain rather thin until now.
Though at the PlayStation's Paris Game Week, Naughty Dog gave us our first proper look at the jarring world of The Last of Us: Part II. To everyone's surprise, the new trailer does not show either smuggler Joe or the teenage girl Ellie, who were the main protagonists in the first installment. Instead, what we see are several new characters along with a completely jarring look at the world of Naughty Dog's GOTY franchise.
Back in December 2016, Sony also showcased a 4-minute announcement trailer of The Last of Us Part 2 at its PlayStation Experience event. The announcement did show Ellie, who is 19 years old now, and revealed her plans to 'kill every one of them'. The announcement trailer further indicated that Ellie becomes the main protagonist in the sequel, while Joel becomes more of a supporting character.
Naughty Dog director Neil Druckmann also shared as to what fans can expect of the upcoming sequel. Interestingly, he revealed in a panel discussion that while the first title focused on love, the next one is more to do with hate. He also confirmed that Gustavo Santaolalla, the composer of the original game's sound, would be making his return for The Last of Us 2 as well.
There's no word on the game's exact release date yet, though rumor has it that The Last of Us: Part 2 will release on the PS4 sometime in 2018.


This season of Doctor Who continues to try to push some boundaries. It'd probably get uncomfortable, or even boring, if they weren't doing the episodes so well.
Yaz (Mandip Gill) receives a gift from her grandmother, Umbreen (Leena Dhingra): a broken watch that must never be fixed, but refuses to speak any more about it. Yaz asks the Doctor (Jodie Whittaker) to take her back to when the watch was broken, but Yaz doesn't actually know when that is. The Doctor uses the psychic circuitry of the TARDIS to take Yaz, Ryan (Tosin Cole), and Graham (Bradley Walsh) back to India in 1947, where they immediately meet a young Hindu man named Prem (Shane Zaza) and a Hindu holy man named Bhakti. Prem takes them to meet a young Umbreen (Amita Suman), who shocks Yaz by revealing that she's going to be married to Prem, a man who A) is Hindu, B) is not Yaz's grandfather, and C) is wearing the watch that brought them there.
He's a sassy one for a man in 1947, too.
The Doctor finds out the date, which, unfortunately, is August 14, 1947, the day before the Partition of India (if you don't know what that is, I will explain after the summary. I was only kinda familiar with it). The Doctor is beset by painful psychic images of demons. They find the holy man murdered and the wedding is delayed until August 15. The Doctor sees two nearby alien figures and assumes they committed the murder. She and the TARDIS trio try to track down the aliens, before she ends up being transported onto their ship. She discovers that the two aliens are Thijarian, a race of near-perfect assassins. The Doctor escapes and uses their technology to keep them away from Prem's house, hoping that will allow the wedding to occur.
The Thijarians might also be Orcs.
Yaz works on trying to figure out what's happening with her grandmother while the Doctor tries to create a repellant for the aliens. However, after studying some of the material found in the alien's ship, she is teleported back onboard. The Thijarians reveal that they are actually the last two of their race. The assassin planet, unsurprisingly, made a lot of enemies and was destroyed. Unable to mourn their dead properly, these two Thijarians vowed to become witnesses to all those who die alone throughout time and space. They were present at the death of the holy man, who they reveal was killed by Prem's brother, Manish (Hamza Jeetooa). It's revealed that they're staying in order to observe the millions of deaths that will follow the Partition, including Prem.
Could have used a better picture, guys.
The Doctor informs the TARDIS trio that they cannot interfere with Prem's death, because otherwise Yaz won't exist. The next morning, Ryan and Graham help Prem prepare for his wedding. Prem, a veteran of World War II, speaks sadly that so many Muslims, Sikhs, and Hindus are fighting now over the Partition, something he feels flies in the face of what he learned from the war. The Doctor officiates the wedding on the border of India and the new country of Pakistan, making Umbreen the first woman married in Pakistan. After the wedding, Prem offers Umbreen his watch as a gift, but drops it, making it the broken watch from the beginning.
This is a beautiful scene, honestly.
Manish leaves the wedding angry at his Hindu brother marrying a Muslim. The Doctor confronts him over the murder of the Holy Man, but Manish reveals he's part of a Hindu Nationalist group that is coming to kill the Muslims. Prem tries to distract the group so that Umbreen and her family can escape, resulting in his death at the hands of a man he fought beside during the war. The Thijarians witness his death and honor him, as the Doctor and the TARDIS trio depart back to the present. Yaz meets with her grandmother again and asks if she was happy with how her life turned out. Umbreen says that she is, even with the bad times.
Literally shooting a comrade dead for loving someone. F*ck you, guy.
This season of Doctor Who is not afraid to take on social issues, obviously, and this episode is a continuation of that, but with a few interesting added elements.
First, let's go ahead and address the Partition of India. So, this doesn't get covered in American Schools much, but in 1945-47, the British Empire was set to allow India to be independent. At the time, there were large populations of Muslims in India's Western half, while most of the rest of India was Hindu until you get to the Buddhists on the Eastern border. So, Britain decided to instead create two states, Pakistan and India. Pakistan for the Muslims, India for the Hindus (and everyone else). Unfortunately, a lot of people near the border of these countries weren't happy about suddenly having their property or family living in other countries. Others weren't happy that there were Hindus in Pakistan or Muslims in India. These tensions quickly came to a head in a series of violent riots that killed at least a few hundred thousand, but likely millions. It also created a massive refugee crisis, with over 14 million people crossing borders over the following 5 years.
If your response to this is "there were Muslims in India?" there are still 172 Million there.
Second, I think subverting the villain in the episode was great. We're introduced to a race of assassins, aliens who have spent their entire existence killing, only for them to have renounced it because, as violence begets violence, their race was inevitably destroyed. The beauty of this working with the theme of the episode so well overshadows my disappointment at the Doctor not having to deal with a race of super-assassins. It helps that the ultimate bad guy, Manish, is portrayed disturbingly realistically. He loves his brother, but, ultimately, he believes that killing all of the people against him is the only solution. He won't pull the trigger, but he lets someone else do it.
Some mild discomfort around Thanksgiving is not a worst-case-scenario.
Third, the fact that the episode is focused around a wedding, and an inter-religious marriage at that, gives it an upbeat air that serves to make it more devastating when it's revealed to be doomed. Since we know WHEN it's doomed, it adds a ticking clock until the Doctor finally accepts that there's nothing to be done. Then, we have to see the Doctor going through the motions of helping Prem and Umbreen, fully aware of what's going to be their fate. It makes her speech at the ceremony in which she calls them "the strongest people on the planet, possibly the universe," through the power of their love, all the sadder.
It was a lovely ceremony, too.
Fourth, this was a great exploration of Yaz. I didn't think she'd gotten her dues yet within the season, so this was a good way of expanding on her. You can even see that she's conflicted about not saving Prem, even though it would result in her never being born. At the end, when she's asking her grandmother if she had a good life, she's basically asking if she did the right thing, which makes it all the better that her grandmother says that having Yaz made everything worthwhile.
I loved this episode. It's not traditional Doctor Who (and, admittedly, I'm antsy to get some again), but when combined with "Rosa," it's becoming apparent that the show is getting better at doing episodes from history that still have relevance in the modern day. This one isn't quite as powerful as the ending of "Rosa," but it's a better overall episode.
Next Next post: Netflix Review – Seven in Heaven: WHAT THE HELL WAS THAT???


text:
/**
 * Apache Licence Version 2.0
 * Please read the LICENCE file
 */
package org.hypothesis.event.interfaces;

import org.hypothesis.data.model.Group;
import org.hypothesis.data.model.User;

/**
 * @author Kamil Morong, Tilioteo Ltd
 *
 *         Hypothesis
 *
 */
@SuppressWarnings("serial")
public interface MainUIEvent extends HypothesisEvent {

	public static final class UserLoginRequestedEvent implements MainUIEvent {
		private final String userName;
		private final String password;

		public UserLoginRequestedEvent(final String userName, final String password) {
			this.userName = userName;
			this.password = password;
		}

		public String getUserName() {
			return userName;
		}

		public String getPassword() {
			return password;
		}
	}

	class GuestAccessRequestedEvent implements MainUIEvent {
	}

	class InvalidLoginEvent implements MainUIEvent {
	}

	class InvalidUserPermissionEvent implements MainUIEvent {
	}

	class UserLoggedOutEvent implements MainUIEvent {
	}

	final class PostViewChangeEvent implements MainUIEvent {
		private final String viewName;

		public PostViewChangeEvent(final String viewName) {
			this.viewName = viewName;
		}

		public String getViewName() {
			return viewName;
		}
	}

	/*
	 * public static class MaskEvent implements MainUIEvent { }
	 *
	 * public static class LegacyWindowClosedEvent implements MainUIEvent { }
	 */

	final class CloseOpenWindowsEvent implements MainUIEvent {
	}

	final class ProfileUpdatedEvent implements MainUIEvent {
	}

	final class UserAddedEvent implements MainUIEvent {
		private final User user;

		public UserAddedEvent(final User user) {
			this.user = user;
		}

		public User getUser() {
			return user;
		}
	}

	final class UserSelectionChangedEvent implements MainUIEvent {
	}

	final class GroupUsersChangedEvent implements MainUIEvent {
		private final Group group;

		public GroupUsersChangedEvent(final Group group) {
			this.group = group;
		}

		public Group getGroup() {
			return group;
		}
	}

	final class GroupAddedEvent implements MainUIEvent {
		private final Group group;

		public GroupAddedEvent(final Group group) {
			this.group = group;
		}

		public Group getGroup() {
			return group;
		}
	}

	final class GroupSelectionChangedEvent implements MainUIEvent {
	}

	final class UserGroupsChangedEvent implements MainUIEvent {
		private final User user;

		public UserGroupsChangedEvent(final User user) {
			this.user = user;
		}

		public User getUser() {
			return user;
		}
	}

	final class UserPacksChangedEvent implements MainUIEvent {
		private final User user;

		public UserPacksChangedEvent(final User user) {
			this.user = user;
		}

		public User getUser() {
			return user;
		}
	}

	final class PackSelectionChangedEvent implements MainUIEvent {
	}

	final class ExportFinishedEvent implements MainUIEvent {
		private final boolean canceled;

		public ExportFinishedEvent(final boolean canceled) {
			this.canceled = canceled;
		}

		public boolean isCanceled() {
			return canceled;
		}
	}

	final class ExportErrorEvent implements MainUIEvent {
	}

	final class ExportProgressEvent implements MainUIEvent {
		private final float progress;

		public ExportProgressEvent(final float progress) {
			this.progress = progress;
		}

		public float getProgress() {
			return progress;
		}
	}

	final class UserPacksRequestRefresh implements MainUIEvent {
	}

}

redpajama_set_name: RedPajamaGithub


Discussion in 'Model 3: Driving Dynamics' started by Knightshade, Jul 28, 2018.
Did the car have a menu in the UI to change it to drive like the Non-P?
The Model S/X test drive P100 cars do (you can pick anything down to a 60D I think) and was curious if the test drive 3s have that too?
No it did not, drove a P3D yesterday evening and damn it was fun. I had a slight doubt in my mind if I should upgrade from AWD to P3D (still have the mystery "Edit design" button) and that doubt is completely gone I'm all in for P3D, it is simply way too much fun to drive this one.
There are only two driving modes, Chill and Sport. I specifically started the test drive in Chill mode and obviously there wasnt much oomph in it, still had good acceleration and very good handling due to AWD. As soon as I switched to Sport mode, the performance came alive right away and the acceleration was instantaneous with quick smooth torque available all the way no matter what speed you are driving at.
I drove a P100D a couple weeks ago and they weren't able to switch it other than taking it out of sport mode. Not sure if the functionality was removed or the sales guy just didn't know how to deal with it.
On S/X cars, when you hold down the "T" logo, a dialog box pops up and you have to type "performance".